9 Meters Biopharma Inc

NASDAQ:NMTR  
1.23
-0.07 (-5.38%)
5:01:07 PM EDT: $1.25 +0.02 (+1.63%)
Earnings Announcements

9 Meters Biopharma Reports Q2 Loss Per Share Of $0.03

Published: 08/12/2021 13:34 GMT
9 Meters Biopharma Inc (NMTR) - Q2 Loss per Share $0.03.
Cash As of June 30, 2021 of $64 Million Expected to Provide Sufficient Cash Runway Into 2023 Based on Current Operating Plan.
Further Company Coverage: .
((reuters.
Briefs@thomsonreuters.
Com;)).
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.04

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.04

More details on our Analysts Page.